CureVac (CVAC) News Today → A ‘DeFi Summer’ Projected! (From Crypto 101 Media) (Ad) Free CVAC Stock Alerts $3.51 +0.32 (+10.03%) (As of 12:48 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 15 at 6:02 PM | marketbeat.comCureVac (NASDAQ:CVAC) Shares Up 5.5%CureVac (NASDAQ:CVAC) Trading Up 5.5%May 10, 2024 | markets.businessinsider.comAnalysts Conflicted on These Healthcare Names: 4D Molecular Therapeutics (FDMT), Revance Therapeutics (RVNC) and CureVac (CVAC)May 10, 2024 | investorplace.com3 Stocks to Purge ASAP Before They're Pulled off Life SupportMay 10, 2024 | investorplace.com3 Stocks to Purge ASAP Before They're Pulled off Life SupportMay 6, 2024 | marketbeat.comCureVac (NASDAQ:CVAC) Stock Price Down 5.4%CureVac (NASDAQ:CVAC) Stock Price Down 5.4%May 3, 2024 | finance.yahoo.comSome Analysts Just Cut Their CureVac N.V. (NASDAQ:CVAC) EstimatesApril 29, 2024 | marketbeat.comCureVac (NASDAQ:CVAC) Trading Up 5.6%CureVac (NASDAQ:CVAC) Trading Up 5.6%April 27, 2024 | finance.yahoo.comCureVac Full Year 2023 Earnings: Misses ExpectationsApril 26, 2024 | seekingalpha.comCureVac N.V. (CVAC) Q4 2023 Earnings Call TranscriptApril 26, 2024 | investing.comCureVac appoints new Chief Business OfficerApril 26, 2024 | msn.comLeerink Partners Downgrades CureVac N.V. (CVAC)April 26, 2024 | marketbeat.comLeerink Partnrs Lowers CureVac (NASDAQ:CVAC) to Market PerformLeerink Partnrs downgraded shares of CureVac from an "outperform" rating to a "market perform" rating in a research report on Thursday.April 25, 2024 | marketbeat.comCureVac (NASDAQ:CVAC) Stock Price Down 8%CureVac (NASDAQ:CVAC) Shares Down 8%April 25, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: CureVac (CVAC) and BioMarin Pharmaceutical (BMRN)April 25, 2024 | finance.yahoo.comCureVac N.V. (NASDAQ:CVAC) Q4 2023 Earnings Call TranscriptApril 25, 2024 | marketbeat.comCureVac (NASDAQ:CVAC) Stock Rating Lowered by SVB LeerinkSVB Leerink lowered CureVac from an "outperform" rating to a "market perform" rating and lowered their price objective for the stock from $12.00 to $4.00 in a research report on Thursday.April 24, 2024 | markets.businessinsider.comEQS-News: CureVac Announces Financial Results for the Fourth Quarter and Full-Year 2023 and Provides Business UpdateApril 24, 2024 | seekingalpha.comCureVac reports Q4 resultsApril 24, 2024 | marketbeat.comCureVac (NASDAQ:CVAC) Hits New 12-Month Low at $2.34CureVac (NASDAQ:CVAC) Reaches New 12-Month Low at $2.34April 24, 2024 | seekingalpha.comCureVac N.V. 2023 Q4 - Results - Earnings Call PresentationApril 24, 2024 | finanznachrichten.deCureVac Announces Start of Combined Phase 1/2 Study in Avian Influenza ; Development in Collaboration with GSKApril 24, 2024 | msn.comCureVac BV reports Q4 resultsApril 24, 2024 | markets.businessinsider.comEQS-News: CureVac Announces Start of Combined Phase 1/2 Study in Avian Influenza (H5N1); Development in Collaboration with GSKApril 23, 2024 | finance.yahoo.comCureVac N.V. (NASDAQ:CVAC) stock most popular amongst private equity firms who own 31%, while individual investors hold 30%April 22, 2024 | marketbeat.comCureVac (NASDAQ:CVAC) Shares Gap Up to $2.44CureVac (NASDAQ:CVAC) Shares Gap Up to $2.44April 18, 2024 | markets.businessinsider.comCureVac (CVAC) Gets a Buy from Leerink PartnersApril 17, 2024 | markets.businessinsider.comEQS-News: CureVac and MD Anderson Enter Strategic Collaboration to Develop Novel Cancer VaccinesApril 16, 2024 | seekingalpha.comCureVac, MD Anderson team up for cancer vaccinesApril 16, 2024 | msn.comCureVac, MD Anderson teams up for cancer vaccinesApril 16, 2024 | marketbeat.comCureVac (NASDAQ:CVAC) Sets New 12-Month Low at $2.54CureVac (NASDAQ:CVAC) Hits New 1-Year Low at $2.54April 15, 2024 | marketbeat.comCureVac (NASDAQ:CVAC) Stock Price Down 4.8%CureVac (NASDAQ:CVAC) Trading Down 4.8%April 5, 2024 | marketbeat.comCureVac (NASDAQ:CVAC) Trading 5.7% Higher CureVac (NASDAQ:CVAC) Stock Price Up 5.7%April 5, 2024 | marketbeat.comCureVac (NASDAQ:CVAC) Receives "Neutral" Rating from GuggenheimGuggenheim reissued a "neutral" rating on shares of CureVac in a report on Friday.April 4, 2024 | msn.comCureVac, GSK Partner Release Data On Influenza Vaccine StudyApril 4, 2024 | marketbeat.comCureVac (NASDAQ:CVAC) Trading Down 2.4%CureVac (NASDAQ:CVAC) Stock Price Down 2.4%April 4, 2024 | markets.businessinsider.comEQS-News: CureVac Announces Promising Phase 2 Interim Data from Seasonal Influenza Vaccine Development Program in Collaboration with GSKApril 2, 2024 | marketbeat.comCureVac (NASDAQ:CVAC) Short Interest UpdateCureVac (NASDAQ:CVAC - Get Free Report) was the target of a large growth in short interest in March. As of March 15th, there was short interest totalling 4,860,000 shares, a growth of 10.7% from the February 29th total of 4,390,000 shares. Based on an average trading volume of 876,200 shares, the days-to-cover ratio is currently 5.5 days. Approximately 5.3% of the company's stock are short sold.March 28, 2024 | marketbeat.comCureVac (NASDAQ:CVAC) Trading 4.3% Higher CureVac (NASDAQ:CVAC) Stock Price Up 4.3%March 27, 2024 | marketbeat.comCureVac (NASDAQ:CVAC) Shares Gap Up to $2.94CureVac (NASDAQ:CVAC) Shares Gap Up to $2.94March 26, 2024 | marketbeat.comCureVac (NASDAQ:CVAC) Shares Down 6.3% CureVac (NASDAQ:CVAC) Shares Down 6.3%March 25, 2024 | finance.yahoo.comCureVac N.V.: CureVac Provides Risk-Tolerant Investors With Pure-Play Exposure to mRNA CandidatesMarch 20, 2024 | marketbeat.comCureVac (NASDAQ:CVAC) Shares Gap Down to $2.94CureVac (NASDAQ:CVAC) Shares Gap Down to $2.94March 19, 2024 | marketbeat.comCureVac (NASDAQ:CVAC) Trading Down 5.9%CureVac (NASDAQ:CVAC) Shares Down 5.9%March 18, 2024 | marketbeat.comCureVac (NASDAQ:CVAC) Hits New 1-Year Low at $3.20CureVac (NASDAQ:CVAC) Hits New 12-Month Low at $3.20March 16, 2024 | finance.yahoo.comCVAC Oct 2024 7.500 callMarch 12, 2024 | marketbeat.comCureVac (NASDAQ:CVAC) Sets New 52-Week Low at $3.27CureVac (NASDAQ:CVAC) Hits New 12-Month Low at $3.27March 8, 2024 | seekingalpha.comCureVac: No Momentum In SightFebruary 5, 2024 | marketbeat.comCureVac (NASDAQ:CVAC) Hits New 52-Week Low at $3.40CureVac (NASDAQ:CVAC) Sets New 12-Month Low at $3.40February 1, 2024 | msn.comJimmy Kimmel Gives Trump A Brutal Reality Check On Just How Unpopular He IsFebruary 1, 2024 | finance.yahoo.comHere's Why We're Watching CureVac's (NASDAQ:CVAC) Cash Burn Situation Get CureVac News Delivered to You Automatically Sign up to receive the latest news and ratings for CVAC and its competitors with MarketBeat's FREE daily newsletter. Email Address Trump’s “Tax Free” Retirement Strategy (Ad)Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem. Protect your retirement savings from the inevitable devaluation of the dollar… CVAC Media Mentions By Week CVAC Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CVAC News Sentiment▼-0.030.55▲Average Medical News Sentiment CVAC News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CVAC Articles This Week▼52▲CVAC Articles Average Week Get CureVac News Delivered to You Automatically Sign up to receive the latest news and ratings for CVAC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: SLN News Today PAHC News Today ORIC News Today LYEL News Today PHAR News Today BCYC News Today ZYME News Today NUVB News Today NRIX News Today ANAB News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CVAC) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportBiden to Drop BOMBSHELL June 13th?Paradigm PressRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldElon to Transform U.S. Economy? Porter & CompanyCharles Payne Demystifies OptionsUnstoppable ProsperityThe most important AI company you've never heard ofManward PressThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyWATCH: The Truth About InflationBirch Gold Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CureVac Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
